Merus logo.jpg
Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer
27 juil. 2020 08h00 HE | Merus N.V.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific...
ZENO.png
Zenosense, Inc.: Update on MIDS Medical Test Strip Development
20 mars 2019 07h30 HE | Zenosense, Inc.
VALENCIA, SPAIN, March 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
Direct Travel Expand
Direct Travel Expands Offerings to Clients with Zeno Travel Booking and Expense Solution in North America
19 mars 2019 08h00 HE | Direct Travel
Denver, March 19, 2019 (GLOBE NEWSWIRE) -- Travel management company Direct Travel, Inc., North America's fastest growing travel management company, today announced the expansion of its agreement...
ZENO.png
Zenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 Million
05 sept. 2018 07h30 HE | Zenosense, Inc.
VALENCIA, SPAIN, Sept. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and...
ZENO.png
Zenosense Trading on the OTCQB Venture Market
10 juil. 2018 08h00 HE | Zenosense, Inc.
VALENCIA, SPAIN, July 10, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTCQB: ZENO, "Zenosense", the "Company"), a healthcare technology company focused on the development and commercialization of the...
Zenosense, Inc.: MID
Zenosense, Inc.: MIDS Shareholder Update 
24 mai 2018 08h43 HE | Zenosense, Inc.
VALENCIA, SPAIN, May 24, 2018 (GLOBE NEWSWIRE) -- Zenosense, Inc. (OTC PINK: ZENO) ("Zenosense", the "Company"), a healthcare technology company primarily focused on the development and...